Farther Finance Advisors’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9K Buy
2,264
+379
+20% +$10.1K ﹤0.01% 3081
2026
Q1
$51.3K Sell
1,885
-53
-3% -$1.59K ﹤0.01% 2980
2025
Q4
$59.7K Buy
1,938
+1,352
+231% +$42.1K ﹤0.01% 2696
2025
Q3
$18K Buy
586
+164
+39% +$4K ﹤0.01% 3117
2025
Q2
$8.72K Buy
422
+204
+94% +$4.19K ﹤0.01% 3140
2025
Q1
$4.07K Sell
218
-266
-55% -$5.58K ﹤0.01% 3148
2024
Q4
$10.1K Buy
484
+425
+720% +$9.34K ﹤0.01% 2378
2024
Q3
$1.44K Sell
59
-175
-75% -$4.68K ﹤0.01% 3118
2024
Q2
$5.82K Buy
234
+62
+36% +$1.76K ﹤0.01% 2335
2024
Q1
$5.21K Sell
172
-2
-1% -$59 ﹤0.01% 2046
2023
Q4
$5.54K Buy
174
+148
+569% +$4.65K ﹤0.01% 1913
2023
Q3
$917 Buy
+26
New +$991 ﹤0.01% 2097

Other funds holding GMAB

Farther Finance Advisors's GMAB Position: Q2 2026 in Review

Farther Finance Advisors increased its Genmab (GMAB) stake by 20% in Q2 2026, buying an estimated $10.1K and bringing the position to 2,264 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3081.

Farther Finance Advisors first reported a position in GMAB in Q3 2023 and has held it in 12 quarters since. 43 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Farther Finance Advisors held 2,264 shares of Genmab worth $61.9K as of Q2 2026.
  • Farther Finance Advisors bought 379 Genmab shares in Q2 2026, an estimated $10.1K.
  • Genmab made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3081 holding.
  • Farther Finance Advisors first reported a position in Genmab in Q3 2023 and has held it in 12 quarters since.
  • 43 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.